| | ||||||||||
| 1 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693) | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| BENZQUINAMIDE DISCONTINUED
| BENZQUINAMIDE | ANTIEMETIC | RECTAL INJECTION | F 39 PERCENT (PMID:581593) HT 1.3 HOUR (PMID581593) | P-GLYCOPROTEIN (PMID1362504) | DOPAMINE D2 RECEPTOR MODULATOR CHEMBL217 DOPAMINE D2 RECEPTOR P14416 D(2) DOPAMINE RECEPTOR HOMO SAPIENS MEMBRANE RECEPTOR 7TM1 SMALLMOL MONOAMINE RECEPTOR DOPAMINE RECEPTOR | ANSM (in French) | |||
